Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide and indomethacin in the prevention of post-ERCP pancreatitis
IRCT20240302061146N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of octreotide and indomethacin in acute pancreatitis (AP), sponsored by Mashhad University of Medical Sciences. Started Apr 2024; status: completed.
02
Drugs
octreotideindomethacin
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on IRCT20240302061146N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240302061146N1.